Abstract
Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.
Tuulikki Sokka and Theodore Pincus
The Journal of Rheumatology December 2002, 29 (12) 2521-2524;
In this issue
Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.
Tuulikki Sokka, Theodore Pincus
The Journal of Rheumatology Dec 2002, 29 (12) 2521-2524;